SPRY4 and melanoma: This study identified 7 immune-related lncRNAs (WAC-AS1, USP30-AS1, LINC01138, SPRY4-AS1, ZNF667-AS1, AC018553.1, and AC008060.3) that were differentially expressed in melanoma tissues compared to healthy skin tissues, and the authors also found that the expression of these lncRNAs was significantly associated with cancer prognosis [38].